More and more people in my Stockton practice open their consultation the same way: “I’m so happy with my weight loss… but I don’t love what it did to my face.” If you’ve lost weight on a GLP-1 medication such as semaglutide or tirzepatide and your face now looks more tired, hollow or “deflated” than you expected, you’re not imagining it, and you’re not alone. The internet calls it “Ozempic face.” After more than 24 years in aesthetics, I want to share what the research actually shows about it, and why my approach is to rebuild collagen and skin quality first, then add volume only where it’s truly needed.
What “Ozempic Face” Really Is (and What It Isn’t)
“Ozempic face” isn’t a medical diagnosis. It’s a nickname for facial changes that can follow fast, significant weight loss. A 2025 systematic review in the Aesthetic Surgery Journal Open Forum looked at 23 published articles and found that GLP-1 medications are linked to facial changes that resemble advanced aging. The authors were also clear that the evidence is still limited by study biases [1]. Plastic surgeons have described the same pattern: hollowing in the mid-face, deeper folds and less firmness, often in people who lost weight quickly [4].
The first study to actually measure this was published in 2025. Researchers compared head and neck scans taken before and after GLP-1 treatment in 20 patients. They found that mid-face volume dropped as weight came off, by about 7% for every 10 kg (22 lbs) lost, and the loss came mostly from the superficial fat pads just under the skin [2]. It’s a small, early study, but it confirms what many of us see in clinic.
Why It’s More Than Just “Lost Fat”
If volume were the whole story, the answer would simply be filler. The research suggests otherwise. A 2024 review in the Aesthetic Surgery Journal explained that the facial aging seen in some GLP-1 patients appears to be multifactorial. It involves loss of fat in and under the skin, and changes in the fat-derived stem cells that help keep skin healthy. These changes can weaken the skin’s structure and quality [3].
In plain language: the skin itself can become thinner, looser and less resilient, not just emptier. That is exactly why I don’t believe the best first step is to fill a face back up.
My Take: Rebuild the Foundation Before Adding Volume
In my practice, I think of the face like a house. If the walls are weakened, adding more furniture doesn’t make it stronger. When skin has lost collagen and firmness, adding a lot of volume on top can look heavy or unnatural, and it doesn’t fix the underlying skin quality. So for most GLP-1 patients, my plan follows this order:
1. Stabilize first
I generally prefer to wait until your weight has leveled off, or is close to your goal, before planning volume correction with filler, because your face is still changing while weight is coming off. But I don’t believe in waiting to support your skin. That’s why I recommend my 10-pound rule (below) while you’re still losing. This timing is my clinical approach, not a rule from a study, and we’ll decide on it together.
2. Rebuild collagen and skin quality
This is where biostimulators and energy-based treatments come in:
Sculptra (poly-L-lactic acid) works gradually by stimulating your own collagen. It is FDA-approved for correcting shallow to deep smile-line (nasolabial fold) contour deficiencies, fine lines and wrinkles in the cheek region, and other facial wrinkles [7]. A 2025 study using 3D imaging in 28 patients found measurable tissue gain and improved skin quality that lasted at least two years. It was a small study that looked back at past patients, so I treat it as encouraging rather than definitive [5].
Radiesse is a calcium hydroxylapatite biostimulator. It is FDA-approved for moderate to severe facial wrinkles and folds such as smile lines, and Radiesse (+) is also approved to improve moderate to severe loss of jawline contour in adults over 21 [8].
RF microneedling combines microneedling with radiofrequency energy to stimulate the skin from within. A 2026 systematic review of 41 studies, including 15 randomized trials, found that RF microneedling improved wrinkle scores and skin density in people with skin laxity and photoaging, with a favorable safety profile [6].
You can learn more on our dermal fillers and biostimulators page and our microneedling and RF microneedling page.
3. Add volume thoughtfully, only where needed
Once the skin is stronger, we can look at whether any area still needs targeted support with an FDA-approved hyaluronic acid filler used for its approved indication. Often, patients need less than they expected, and the result looks more like them.
My 10-Pound Rule for Skin Laxity During Weight Loss
Here’s a recommendation I give every client on a GLP-1 or medical weight-loss plan: for every 10 pounds you lose, come in for a skin check and a collagen-supporting treatment. Research shows facial volume drops steadily as weight comes off, about 7% of mid-face volume for every 22 pounds in one imaging study [2], and the skin itself can lose firmness along the way [3]. Supporting your skin in step with your weight loss is far easier than trying to correct a lot of laxity all at once at the end.
At each 10-pound visit, I choose from treatments we offer at Skin Glo based on your skin:
RF microneedling: my most common choice for firmness and texture. A systematic review of 41 studies found improvements in wrinkle scores and skin density in people with skin laxity [6].
Sculptra: a gradual collagen stimulator, FDA-approved for smile-line contour deficiencies, fine lines and wrinkles in the cheek region, and other facial wrinkles [5,7].
Radiesse: a calcium hydroxylapatite biostimulator, FDA-approved for moderate to severe facial wrinkles and folds; Radiesse (+) is also approved for jawline contour [8].
Which treatment you need, and how often, depends on how quickly you’re losing weight, your age, your skin quality and your goals. The 10-pound rhythm is my clinical recommendation; research hasn’t yet defined an exact interval, so we’ll tailor it to you. Many of our clients from Stockton, Lodi, Manteca and Tracy schedule these check-ins alongside their weight-management visits.
Who This Approach Is Right For (and Who Should Wait)
A good fit: adults who have lost a meaningful amount of weight, are at or near a stable weight, and want natural-looking improvement in firmness, smile lines and overall skin quality, without looking “done.”
Better to wait: anyone still losing weight quickly, anyone who is pregnant or breastfeeding, and anyone with an active skin infection or a medical condition that needs to be cleared first. Biostimulators also work gradually, over weeks to months, so they aren’t the right choice if you need a change before an event next week.
Weight loss on a GLP-1 is a real health achievement, and I never want anyone to feel they have to choose between their health and their confidence. If you’re on a medical weight-loss program, including through our weight management services, it’s worth talking about your skin early so we can plan ahead.
Frequently Asked Questions
Is “Ozempic face” permanent?
Facial changes from weight loss don’t simply reverse on their own, but they can often be improved. Research on why it happens and how best to treat it is still evolving [1,3].
Will I need filler?
Not necessarily. Many of my patients do well starting with collagen-building treatments and skin-quality procedures. We only add filler where it will make a meaningful, natural difference.
How long until I see results from Sculptra or RF microneedling?
Both work gradually because your body is building new collagen. Most plans involve a series of sessions, and changes appear over the following weeks to months. Individual results vary.
Should I stop my GLP-1 medication to protect my face?
No. Never change a prescribed medication for cosmetic reasons without talking to your prescribing provider. Your overall health comes first, and we can work alongside your medical plan.
Do you see patients from outside Stockton?
Yes. We welcome clients from Lodi, Manteca, Tracy, Lathrop, Elk Grove, Sacramento and the surrounding Central Valley.
Let’s Create Your Plan Together
Every face changes differently with weight loss. The best results come from an honest assessment and a plan built for you, not a one-size-fits-all package. I’d love to meet you, listen to your goals and talk through your options.
Book your private consultation at Skin Glo Aesthetics →
Skin Glo Aesthetics operates with physician oversight by Dr. Arman Serebrakian.
References
Daneshgaran G, Shauly O, Gould DJ. “Ozempic face” in plastic surgery: a systematic review of the literature on GLP-1 receptor agonist mediated weight loss and analysis of public perceptions. Aesthet Surg J Open Forum. 2025;7:ojaf056. doi:10.1093/asjof/ojaf056
Sharma RK, Vittetoe KL, Barna AJ, et al. Radiographic midfacial volume changes in patients on GLP-1 agonists. Otolaryngol Head Neck Surg. 2025;173(2):360-366. doi:10.1002/ohn.1209
Ridha Z, Fabi SG, Zubar R, Dayan SH. Decoding the implications of glucagon-like peptide-1 receptor agonists on accelerated facial and skin aging. Aesthet Surg J. 2024;44(11):NP809-NP818. doi:10.1093/asj/sjae132
Mansour MR, Hannawa OM, Yaldo MM, Nageeb EM, Chaiyasate K. The rise of “Ozempic face”: analyzing trends and treatment challenges associated with rapid facial weight loss induced by GLP-1 agonists. J Plast Reconstr Aesthet Surg. 2024;96:225-227. doi:10.1016/j.bjps.2024.07.051
Angelo-Khattar M. Poly-L-lactic acid in facial rejuvenation: volumetric data supporting regenerative outcomes. Clin Cosmet Investig Dermatol. 2025;18:3653-3666. doi:10.2147/CCID.S566829
Kumar N, Kim HM, Nishikawa A, Heo CY, Wu WTL. Effectiveness of radiofrequency microneedling in the treatment of dermatological conditions: a systematic review. Aesthetic Plast Surg. 2026;50(13):5282-5317. doi:10.1007/s00266-026-05834-y
US Food and Drug Administration. Premarket approval P030050/S039: Sculptra – correction of fine lines and wrinkles in the cheek region. April 25, 2023. FDA PMA database
US Food and Drug Administration. Summary of Safety and Effectiveness Data: RADIESSE (+) Lidocaine injectable implant, PMA P050052/S129. September 1, 2021. FDA document
This article is for educational purposes only and is not medical advice. Individual results vary. A medical consultation is required to determine candidacy.
